{"0": "Aquatic Ecotoxicology", "1": "Serotonin Receptor Modulation in SSRI Treatment", "2": "Analytical Methods for SSRI Detection and Quantification", "3": "SSRIs for OCD", "4": "Risk of Prenatal Exposure", "5": "SSRIs for Pediatric Depression", "6": "SSRIs and the Cytochrome P450 System", "7": "Impact of SSRIs on Neurogenesis", "8": "The Chronic Unpredictable Mild Stress Model of Depression", "9": "SSRIs Effect on Neural Processing of Emotional Cues", "10": "Risk of Prenatal Exposure (Rodents)", "11": "SSRIs for PTSD", "12": "SSRIs in Forced Swimming Test", "13": "SSRI Utilization Patterns", "14": "Fluvoxamine for Depression", "15": "Inflammatory Biomarkers", "16": "Sexual Dysfunction", "17": "SSRIs Effect on Fear", "18": "Post-Stroke SSRI Use", "19": "Escitalopram for Depression", "20": "Serotonin Transporter Gene and Antidepressant Response", "21": "Treatment Strategies and Outcomes in Depression", "22": "SSRIs for Pain", "23": "SSRIs for Depression in Patients with Cardiovascular Disease", "24": "SSRIs in Dementias", "25": "Serotonin Syndrome", "26": "SSRIs for Weight Management", "27": "Paroxetine Binding to Serotonin Transporter", "28": "Bleeding Risk", "29": "Antidepressant-like Effects of Herbal Extracts in Animal Models", "30": "Oncopreventive and Oncolytic Properties of SSRIs", "31": "Suicice Risk", "32": "Fracture Risk", "33": "SSRIs for Generalized Anxiety Disorder", "34": "SSRIs for Panic Disorder", "35": "Pharmacological Reviews", "36": "SSRIs for Bipolar Depression", "37": "Hepatotoxic Risk", "38": "Fluvoxamine for Covid 19", "39": "Pharmacoeconomics of SSRIs for Depression", "40": "SSRIs Effect on Sleep", "41": "Venlafaxine vs SSRIs for Depression", "42": "SSRI Effects on Lactation", "43": "SSRIs for Depression in Diabetes Patients", "44": "SSRIs for Menopausal Vasomotor Symptoms (Hot flashes)", "45": "Pharmacovigilance of SSRIs", "46": "Premature Ejaculation", "47": "SSRIs for Depression with Cognitive Impairment", "48": "QTC Prolongation", "49": "Extrapyramidal Reactions Risk", "50": "SSRIs for Irritable Bowel Syndrome", "51": "SSRIs for Alcohol Dependence", "52": "SSRIs for Premenstrual Dysphoric Disorder (PMDD)", "53": "Neuroimaging of Serotonin Transporters", "54": "SSRIs for (Psycho)dermatological Diseases", "55": "Synthetic Chemistry of Paroxetine", "56": "SSRIs for Autism Spectrum Disorders", "57": "SSRIs for Eating Disorders", "58": "SSRIs for Depression in Parkinsons Patients", "59": "SSRIs for Depression in in Epileptic Patients", "60": "SSRIs Effects on Ion Channels", "61": "SSRIs and Augmentation for Treatment Resistant Depression", "62": "Environmental Degradation of Antidepressants", "63": "Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity", "64": "Laboratory Techniques for drug analysis", "65": "SSRIs for Social Anxiety Disorder", "66": "Forensic Toxicology of Fatal Overdoses", "67": "SSRIs (Fluvoxamine) for Schizophrenia", "68": "SSRIs Effect on Pulmonary Hypertension", "69": "SSRIs for Body Dysmorphic Disorder (BDD)", "70": "Antidepressant Drug Design", "71": "Serotonergic Modulation of Cocaine Effects", "72": "Pharmacogenetics in SSRI Treatment", "73": "Non-SERT Transporters in Antidepressant Action", "74": "SSRIs for Depression, Comparative Effectiveness", "75": "SSRIs for Geriatric Depression", "76": "SERT Binding Mechanisms", "77": "Astrocyte Receptors as a Target for SSRIs", "78": "SSRIs for Borderline Personality Disorder", "79": "Agomelatin for Depression", "80": "Depression Treatment Guidelines", "81": "Sertraline for Depression", "82": "Withdrawal Symptoms", "83": "Hyponatremia Risk", "84": "SSRIs Effect on Dopamine Receptors", "85": "SSRIs Effects on Antimicrobials and Gut Microbiome", "86": "SSRIs for Depression after Traumatic Brain Injury", "87": "Antifungal Activity of Sertraline", "88": "Neurometabolite Changes with Antidepressants", "89": "Galanin System in Antidepressant Action", "90": "SSRIs for Fibromyalgia", "91": "SSRI Crystal Structure and Complexation", "92": "SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients", "93": "SSRIs in Model Organisms ( C. Elegans and Drosophilia)", "94": "SSRIs for Depression in Cancer Patients", "95": "SSRIs for Postpartum Depression", "96": "SSRIs Long-term Efficacy and Recurrent Depression", "97": "Canine Behavioral Disorders", "98": "Gatways to Clinical Trials", "99": "SRRIs and Ocular Safety", "100": "Folate for Depression", "101": "SSRIs for Depression in Patients with Kidney Disease", "102": "Psilocybin for Depression", "103": "SSRIs Effect on Reinforcement Learning in Rodents", "104": "SSRIs for Behavioral Addictions", "105": "St. John's Wort for Depression", "106": "SSRIs for Migraine", "107": "Vilazodone for Depression", "108": "SSRIs for Dysthymia", "109": "SSRIs for Enuresis", "110": "Paroxetines as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor", "111": "SSRIs for Trichotillomania", "112": "Transcranial Direct Current Stimulation (tDCS) for Depression", "113": "SSRIs for Burning Mouth Syndrome", "114": "SSRIs for Depression in Patients with Chronic Obstructive Pulmonary Disease (COPD)", "115": "SSRIs for the Mangement of Multiple Sclerosis", "116": "SSRIs for Interferon-Induced Depression", "117": "SSRIs for Depression in HIV-positive Patients", "118": "Acupuncture for Depression", "119": "SSRIs for Syncope", "120": "SSRIs for Smoking Cessation", "121": "Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression", "122": "SSRIs for Tinnitus ", "123": "Exercise for Depression", "124": "SSRI-Methylphenidate Interactions", "125": "SSRIs for Narcolepsy", "126": "SSRIs for OCD-like behaviors", "127": "SSRIs in the Treatment of Huntington Disease", "128": "SSRIs for Congenital Myasthenic Syndrome (SCCMS)", "129": "Tryptophan Depletion in Depression", "130": "Risk of Microscopic Colitis", "131": "Herbal Remedies for SSRI-Induced Sexual Dysfunction", "132": "Adulterants of SSRIs in Weight Loss Supplements", "133": "SSRIs for Mutism", "134": "SSRIs for Tourette's Syndrome", "135": "Childhood Trauma and Antidepressant Response", "136": "SSRIs Risk of Apathy syndrome", "137": "Serotonin Transporter in Primate Models", "138": "Blood-Brain Barrier Drug Transport", "139": "Polypharmacy Effects in Aging Models", "140": "Gateways to Clinical Trials", "141": "SSRIs for Infertile Women", "142": "Fewer than 10", "143": "Fewer than 10"}